Kaisa Group sells Target Company to Kaisa Health for RMB 21.6 million

Reuters

Mar 19

Kaisa Group sells Target Company to <a href="https://laohu8.com/S/00876">Kaisa Health</a> for RMB 21.6 million

A Kaisa unit agreed to sell 100% of Embrace Blossom to Kaisa Health for RMB21.6 million, to be settled by issuing 2.79 million Kaisa Health shares at HKD8.75 each (post share consolidation).
Through the target group, Embrace Blossom indirectly holds 54.84% of Qinghai Pharmaceutical, which manufactures and sells pharmaceutical products in China.
Kaisa’s effective interest in Qinghai Pharmaceutical is expected to fall to 24.17% from 54.29%, representing a disposal of 30.12% effective interest.
After completion, Kaisa’s stake in Kaisa Health is expected to rise by 1.53 percentage points to 44.52%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kaisa Group Holdings Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: PFC9Q9K71RH3QS86) on March 19, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2620484022"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2620484022\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2620484022?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-19 16:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620484022","market":"nz","top_or_hot":-1,"title":"Kaisa Group sells Target Company to Kaisa Health for RMB 21.6 million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Kaisa Group sells Target Company to <a href=\"https://laohu8.com/S/00876\">Kaisa Health</a> for RMB 21.6 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          A Kaisa unit agreed to sell 100% of Embrace Blossom to Kaisa Health for RMB21.6 million, to be settled by issuing 2.79 million Kaisa Health shares at HKD8.75 each (post share consolidation).\n        </li>\n<li>\n          Through the target group, Embrace Blossom indirectly holds 54.84% of Qinghai Pharmaceutical, which manufactures and sells pharmaceutical products in China.\n        </li>\n<li>\n          Kaisa’s effective interest in Qinghai Pharmaceutical is expected to fall to 24.17% from 54.29%, representing a disposal of 30.12% effective interest.\n        </li>\n<li>\n          After completion, Kaisa’s stake in Kaisa Health is expected to rise by 1.53 percentage points to 44.52%.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kaisa Group Holdings Ltd. published the original content used to generate this news brief via <a href=\"https://laohu8.com/S/SPXCF\">Singapore Exchange</a> Limited (SGX) (Ref. ID: PFC9Q9K71RH3QS86) on March 19, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kaisa Group sells Target Company to Kaisa Health for RMB 21.6 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKaisa Group sells Target Company to Kaisa Health for RMB 21.6 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-19 16:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Kaisa Group sells Target Company to <a href=\"https://laohu8.com/S/00876\">Kaisa Health</a> for RMB 21.6 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          A Kaisa unit agreed to sell 100% of Embrace Blossom to Kaisa Health for RMB21.6 million, to be settled by issuing 2.79 million Kaisa Health shares at HKD8.75 each (post share consolidation).\n        </li>\n<li>\n          Through the target group, Embrace Blossom indirectly holds 54.84% of Qinghai Pharmaceutical, which manufactures and sells pharmaceutical products in China.\n        </li>\n<li>\n          Kaisa’s effective interest in Qinghai Pharmaceutical is expected to fall to 24.17% from 54.29%, representing a disposal of 30.12% effective interest.\n        </li>\n<li>\n          After completion, Kaisa’s stake in Kaisa Health is expected to rise by 1.53 percentage points to 44.52%.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kaisa Group Holdings Ltd. published the original content used to generate this news brief via <a href=\"https://laohu8.com/S/SPXCF\">Singapore Exchange</a> Limited (SGX) (Ref. ID: PFC9Q9K71RH3QS86) on March 19, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2242646821.SGD","symbol_name":"Fidelity Global Dividend Plus A-MINCOME(G)-SGD","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL6JJQ6G:1","article_id":"2620484022","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2620484022","pubTimestamp":1773910457,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"A Kaisa unit agreed to sell 100% of Embrace Blossom to Kaisa Health for RMB21.6 million, to be settled by issuing 2.79 million Kaisa Health shares at HKD8.75 each .Through the target group, Embrace Blossom indirectly holds 54.84% of Qinghai Pharmaceutical, which manufactures and sells pharmaceutical products in China.Kaisa’s effective interest in Qinghai Pharmaceutical is expected to fall to 24.17% from 54.29%, representing a disposal of 30.12% effective interest.After completion, Kaisa’s stake in Kaisa Health is expected to rise by 1.53 percentage points to 44.52%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kaisa Group Holdings Ltd. published the original content used to generate this news brief via Singapore Exchange Limited   on","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2242646821.SGD":"Fidelity Global Dividend Plus A-MINCOME(G)-SGD","LU2242652126.USD":"FIDELITY FUNDS GLOBAL DIVIDENDS PLUS \"A\" (USD) INC","LU2401740654.USD":"FIDELITY SUSTAINABLE GLOBAL DIVIDEND PLUS \"A\" (USD) INC","00876":"佳兆业健康","LU1920062954.HKD":"FIDELITY FUNDS GLOBAL DIVIDEND PLUS \"A\" (HKDHDG) INC","BK0239":"医药制造","SG9999000343.SGD":"Schroder Singapore Trust A Dis SGD","BK1507":"粤港澳大湾区","BK6033":"金融交易所和数据","LU0192582467.USD":"SCHRODER ISF ASIAN EQUITY YIELD \"A\" (USD) INC MF","LU0898667661.SGD":"JPMorgan Funds - Asia Pacific Income A (mth) SGD-H","SG9999003826.SGD":"日兴资管新加坡股息基金 SGD","LU0532188223.SGD":"JPMorgan Funds - ASEAN Equity A (acc) SGD","LU1839390173.USD":"JPM ASEAN EQUITY \"A\" (USD) INC","LU0205439572.USD":"富达亚太股息基金","SG9999001135.SGD":"United ASEAN Fund SGD","SG9999016042.SGD":"Schroder Singapore Trust A Acc SGD","LU0441851309.USD":"JPM ASEAN EQUITY \"A\" ACC","IE00BKZH1Z71.USD":"BNY MELLON ASIAN INCOME \"B\" (USD) ACC","BK0188":"融资融券","01638":"佳兆业集团","BK0077":"质押式回购","SG9999014492.USD":"NIKKO AM ASEAN EQUITY \"A\" (USD) ACC","SGXZ58947870.SGD":"LIONGLOBAL SINGAPORE DIVIDEND EQUITY (SGDHDG) INC","BK1240":"房地产开发","SG9999014484.SGD":"Nikko AM ASEAN Equity Fund A SGD","BK6516":"银行与投资服务概念","LU0877626530.USD":"FIDELITY ASIA PACIFIC DIVIDEND \"A\" (USD) INC MONTHLY (G)","LU1920063259.USD":"FIDELITY FUNDS GLOBAL DIVIDEND PLUS \"A\" (USDHDG) INC","BK1555":"内房股","BK6523":"ESG概念","SGXZ27511609.SGD":"NIKKO AM SINGAPORE DIVIDEND EQUITY \"SGD\" (SGD) ACC","BK1222":"医疗保健用品","LU1119993845.HKD":"FIDELITY ASIA PACIFIC DIVIDEND \"A\" (HKDHDG) INC","SG9999004360.SGD":"Nikko AM Shenton Thrift Fund SGD","SG9999001846.SGD":"Schroder Asian Equity Yield A Dis SGD","LU0831103253.SGD":"JPMorgan Funds - Asia Pacific Income A (mth) SGD","LU0326948709.USD":"SCHRODER ISF ASIAN TOTAL RETURN \"A\" (USD) ACC","LU2242646235.USD":"FIDELITY FUNDS GLOBAL DIVIDENDS PLUS \"A\" (USD) ACC","LU0188438112.USD":"SCHRODER ISF ASIAN EQUITY YIELD \"A\" ACC","SG9999013460.SGD":"LionGlobal Singapore Dividend Equity Fund SGD","SG9999013486.USD":"LIONGLOBAL SINGAPORE DIVIDEND EQUITY (USD) INC A","SG9999006266.SGD":"MANULIFE SINGAPORE EQUITY \"A\" (SGD) ACC","BK1582":"深圳本地概念股","SG9999013478.USD":"利安新加坡股息基金"},"translate_title":"佳兆业集团向佳兆业健康出售目标公司2160万元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00876":1.91,"01638":1.96},"content_text":"Kaisa Group sells Target Company to Kaisa Health for RMB 21.6 million\n    \n\n\n          A Kaisa unit agreed to sell 100% of Embrace Blossom to Kaisa Health for RMB21.6 million, to be settled by issuing 2.79 million Kaisa Health shares at HKD8.75 each (post share consolidation).\n        \n\n          Through the target group, Embrace Blossom indirectly holds 54.84% of Qinghai Pharmaceutical, which manufactures and sells pharmaceutical products in China.\n        \n\n          Kaisa’s effective interest in Qinghai Pharmaceutical is expected to fall to 24.17% from 54.29%, representing a disposal of 30.12% effective interest.\n        \n\n          After completion, Kaisa’s stake in Kaisa Health is expected to rise by 1.53 percentage points to 44.52%.\n        \n\n\n\n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kaisa Group Holdings Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: PFC9Q9K71RH3QS86) on March 19, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}